Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • Laia
    Junior Member
    • Apr 2013
    • 2

    Disappearence of samples along with helicos

    Hi all,

    I was writing to see if any of you encountered themselves in the same situation as us regarding Helicos.
    Some months ago, before Helicos collapsed, we send them some samples for sequencing. Even tought there were rumours of the collapse, they promised us that the samples would be sequenced.
    After the collapse, we were contacted by Daniel Jones of Helicos, promising again that the we would get our results because he was going to buy the technology and keep on with the sequencing. Five months later Daniel Jones has dissapeared the face of the earth along with our samples. It took several month of work and effort to get those samples and we would very much want to recover them at least.

    Can anyone help us? Is anyone in the same situation?

    Thank you!!

    Laia Masvidal, PhD
    Karolinska Institutet (Sweden)
  • Kletz_AUS
    Junior Member
    • May 2012
    • 5

    #2
    Laia, have you had any luck tracking down Mr. Jones?

    The Helicos website is no longer online so I am assuming his old email doesn't work: [email protected].

    Perhaps you could try contacting him through LinkedIn. His title is still displayed as Field Application Scientist at Helicos BioSciences.

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
      by SEQadmin2


      Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

      The systematic characterization of the human proteome has
      ...
      07-20-2026, 11:48 AM
    • SEQadmin2
      Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
      by SEQadmin2



      Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
      ...
      07-09-2026, 11:10 AM
    • SEQadmin2
      Cancer Drug Resistance: The Lingering Barrier to Rising Survival
      by SEQadmin2



      Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

      There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
      07-08-2026, 05:17 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, 07-20-2026, 11:10 AM
    0 responses
    14 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-13-2026, 10:26 AM
    0 responses
    31 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-09-2026, 10:04 AM
    0 responses
    42 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-08-2026, 10:08 AM
    0 responses
    27 views
    0 reactions
    Last Post SEQadmin2  
    Working...